International Biotechnology (IBT) Competitors GBX 678 +4.00 (+0.59%) (As of 11/21/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendHeadlinesInsider Trades IBT vs. JPE, BRWM, N91, TRY, IEM, RICA, SAIN, BBGI, JEO, and APEOShould you be buying International Biotechnology stock or one of its competitors? The main competitors of International Biotechnology include JPMorgan Elect plc - Managed Growth (JPE), BlackRock World Mining Trust (BRWM), Ninety One Group (N91), TR Property Investment Trust (TRY), Impax Environmental Markets (IEM), Ruffer Investment (RICA), Scottish American Investment (SAIN), BBGI Global Infrastructure (BBGI), European Opportunities Trust (JEO), and abrdn Private Equity Opportunities (APEO). These companies are all part of the "asset management" industry. International Biotechnology vs. JPMorgan Elect plc - Managed Growth BlackRock World Mining Trust Ninety One Group TR Property Investment Trust Impax Environmental Markets Ruffer Investment Scottish American Investment BBGI Global Infrastructure European Opportunities Trust abrdn Private Equity Opportunities JPMorgan Elect plc - Managed Growth (LON:JPE) and International Biotechnology (LON:IBT) are both small-cap finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, valuation, analyst recommendations, community ranking, media sentiment and dividends. Does the MarketBeat Community believe in JPE or IBT? International Biotechnology received 67 more outperform votes than JPMorgan Elect plc - Managed Growth when rated by MarketBeat users. Likewise, 77.71% of users gave International Biotechnology an outperform vote while only 62.73% of users gave JPMorgan Elect plc - Managed Growth an outperform vote. CompanyUnderperformOutperformJPMorgan Elect plc - Managed GrowthOutperform Votes6962.73% Underperform Votes4137.27% International BiotechnologyOutperform Votes13677.71% Underperform Votes3922.29% Does the media refer more to JPE or IBT? In the previous week, International Biotechnology had 1 more articles in the media than JPMorgan Elect plc - Managed Growth. MarketBeat recorded 1 mentions for International Biotechnology and 0 mentions for JPMorgan Elect plc - Managed Growth. International Biotechnology's average media sentiment score of 0.59 beat JPMorgan Elect plc - Managed Growth's score of 0.00 indicating that International Biotechnology is being referred to more favorably in the news media. Company Overall Sentiment JPMorgan Elect plc - Managed Growth Neutral International Biotechnology Positive Is JPE or IBT a better dividend stock? JPMorgan Elect plc - Managed Growth pays an annual dividend of GBX 0.17 per share and has a dividend yield of 0.0%. International Biotechnology pays an annual dividend of GBX 29 per share and has a dividend yield of 4.3%. JPMorgan Elect plc - Managed Growth pays out 22.9% of its earnings in the form of a dividend. International Biotechnology pays out 6,041.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Which has higher valuation & earnings, JPE or IBT? International Biotechnology has lower revenue, but higher earnings than JPMorgan Elect plc - Managed Growth. JPMorgan Elect plc - Managed Growth is trading at a lower price-to-earnings ratio than International Biotechnology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJPMorgan Elect plc - Managed Growth£104.78M9.57N/A£0.751,250.00International Biotechnology£24.14M10.38£18.19M£0.481,412.50 Do insiders and institutionals have more ownership in JPE or IBT? 45.2% of International Biotechnology shares are held by institutional investors. 4.2% of International Biotechnology shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Is JPE or IBT more profitable? International Biotechnology has a net margin of 75.33% compared to JPMorgan Elect plc - Managed Growth's net margin of 0.00%. International Biotechnology's return on equity of 6.25% beat JPMorgan Elect plc - Managed Growth's return on equity.Company Net Margins Return on Equity Return on Assets JPMorgan Elect plc - Managed GrowthN/A N/A N/A International Biotechnology 75.33%6.25%3.57% SummaryInternational Biotechnology beats JPMorgan Elect plc - Managed Growth on 12 of the 15 factors compared between the two stocks. Ad Colonial Metals“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…>> YES! Send Me My FREE Gold Guide! Get International Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for IBT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IBT vs. The Competition Export to ExcelMetricInternational BiotechnologyAsset Management IndustryFinancial SectorLON ExchangeMarket Cap£250.59M£869.69M£3.51B£1.49BDividend Yield4.39%13.19%4.55%11.24%P/E Ratio1,412.50772.79427.591,573.24Price / Sales10.3813,677.952,055.72209,385.20Price / Cash155.7487.4850.2935.08Price / Book0.911.771.492.90Net Income£18.19M£62.32M£348.42M£137.03M7 Day Performance-5.31%-0.23%0.23%-0.55%1 Month Performance-2.31%-0.50%0.78%3.56%1 Year Performance18.12%10.60%15.80%104.07% International Biotechnology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IBTInternational BiotechnologyN/AGBX 678+0.6%N/A+17.0%£250.59M£24.14M1,412.50N/ANews CoverageJPEJPMorgan Elect plc - Managed GrowthN/AGBX 937.50flatN/A+0.0%£1.00B£104.78M1,250.00N/ABRWMBlackRock World Mining TrustN/AGBX 516+1.6%N/A-10.1%£986.49M£8.72M-7,300.00147,000Dividend AnnouncementNews CoveragePositive NewsN91Ninety One Group0.4894 of 5 starsGBX 162.70+4.6%GBX 173+6.3%-16.4%£982.07M£588.50M903.891,180Dividend CutNews CoverageGap UpTRYTR Property Investment TrustN/AGBX 306-0.3%N/A-2.4%£971.09M£-528,720,000.00-174.5426IEMImpax Environmental MarketsN/AGBX 379.50+0.3%N/A+2.4%£952.85M£1.57M-9,487.50N/ANews CoverageRICARuffer InvestmentN/AGBX 270+0.4%N/A-0.2%£937.01M£19.58M9,000.00N/ASAINScottish American InvestmentN/AGBX 505+1.0%N/A-1.8%£900.52M£103.33M1,010.00N/ABBGIBBGI Global InfrastructureN/AGBX 125+0.8%N/A-7.0%£893.41M£68.47M1,548.611,160JEOEuropean Opportunities TrustN/AGBX 843-2.4%N/A+0.0%£886.70M£-62,326,000.00-12.93N/AAPEOabrdn Private Equity OpportunitiesN/AN/AN/A+29.0%£880.29M£80.21M1,435.00N/A Related Companies and Tools Related Companies JPMorgan Elect plc - Managed Growth Competitors BlackRock World Mining Trust Competitors Ninety One Group Competitors TR Property Investment Trust Competitors Impax Environmental Markets Competitors Ruffer Investment Competitors Scottish American Investment Competitors BBGI Global Infrastructure Competitors European Opportunities Trust Competitors abrdn Private Equity Opportunities Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:IBT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding International Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share International Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IBT Stock Alerts